Drug Approval | February 23, 2025
Briefs: Syngene International and Cipla
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
Ibuprofen and famotidine combination is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
Observations are largely around improvement of procedures and practices
Around 100 million people live with COPD in China, accounting for almost 25% of all COPD cases globally
Revenue from operations also dropped 8.3 per cent at Rs. 133.5 crore in Q3 FY25
Subscribe To Our Newsletter & Stay Updated
